Asia Pacific Heparin Market Size & Outlook, 2023-2030
Asia Pacific heparin market, 2018-2030 (US$M)
Related Markets
Asia Pacific heparin market highlights
- The Asia Pacific heparin market generated a revenue of USD 1,859.7 million in 2023.
- The market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 1,859.7 million |
| Market revenue in 2030 | USD 2,436.9 million |
| Growth rate | 3.9% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 25.1% of the global heparin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,436.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 85.32% in 2023. Horizon Databook has segmented the Asia Pacific heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is a lucrative market for heparin due to the presence of a large population suffering from chronic diseases, such as cardiovascular and renal disorders. Growing elderly population is anticipated to increase the burden of stroke, the prevalence of which ranges between 483 to 116 per 100,000 in the region.
According to the NCBI, in 2019, the population-wide estimates for VTE in Hong Kong and Taiwan were 19.9 and 15.9 per 100,000, respectively. A study conducted in Asian hospitals showed that VTE prevalence ranged from 11 to 88 cases per 10,000 admissions.
This growing prevalence is anticipated to act as a major market driver. Moreover, changing lifestyles leading to hypertension & stress, an increase in consumption of alcohol & tobacco, and growing disposable income are likely to contribute to market growth in Asia Pacific.
Reasons to subscribe to Asia Pacific heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific heparin market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific heparin market size, by country, 2018-2030 (US$M)
Asia Pacific Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
